12 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
15131245	86	SR147778 [5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a new potent and selective antagonist of the CB1 cannabinoid receptor: biochemical and pharmacological characterization.	Sanofi-Synthelabo Recherche
12721338	61	N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: I. in vitro characterization and pharmacokinetic properties.	Pudue Pharma Discovery Research
11907155	384	Elucidation of vasoactive intestinal peptide pharmacophore for VPAC(1) receptors in human, rat, and guinea pig.	National Institutes of Health
11082453	77	ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2, 3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties: I. In vitro characterization and acute antinociceptive effects in the mouse.	Abbott Laboratories
9454810	72	SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor.	Sanofi Recherche
9152366	4	Novel cyclic peptide agonist of high potency and selectivity for the type II vasoactive intestinal peptide receptor.	University of California San Francisco
8012715	38	GR113808: a novel, selective antagonist with high affinity at the 5-HT4 receptor.	Glaxo Group Research
7716273	19	Properties of the VIP-PACAP type II receptor stably expressed in CHO cells.	UniversitÉ
1997328	39	Structural requirements for the binding of the pituitary adenylate-cyclase-activating peptide to receptors and adenylate-cyclase activation in pancreatic and neuronal membranes.	UniversitÉ
7518514	46	(S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.	Abbott Laboratories
1352553	38	Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist.	University of North Carolina